跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DARIFENACINA ARISTO 7,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DARIFENACINA ARISTO 7,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
DARIFENACINA ARISTO 7,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Aristo Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 5, 2022
Approval ID
be2c29f2d2966503
Company
Aristo Pharma Gmbh
Type
Standard
Approval Details
Approval Id
be2c29f2d2966503
Drug Cima Aemps Name
DARIFENACINA ARISTO 7,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
86780
Holder Company Name
Aristo Pharma Gmbh
Marketing Company Name
Aristo Pharma Iberia S.L.
Holder Company Detail Path
/organization/aristo-pharma-gmbh
Authorization Date
2022-04-05
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
7,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Aristo Pharma Gmbh
Company Detail Path
/organization/aristo-pharma-gmbh
Company Information
Pharmaceutical Company Name
Aristo Pharma GmbH
Country Name
Germany
Website
http://www.aristo-pharma.de
Active Ingredients
DARIFENACINA HIDROBROMURO
8,923 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 5, 2022
Approval ID
be2c29f2d2966503
Type
Standard
Back to CIMA-AEMPS Approvals